HK1202542A1 - 新型吡唑化合物 - Google Patents

新型吡唑化合物

Info

Publication number
HK1202542A1
HK1202542A1 HK15103083.5A HK15103083A HK1202542A1 HK 1202542 A1 HK1202542 A1 HK 1202542A1 HK 15103083 A HK15103083 A HK 15103083A HK 1202542 A1 HK1202542 A1 HK 1202542A1
Authority
HK
Hong Kong
Prior art keywords
pyrazole compounds
sglt1 inhibitors
sglt1
inhibitors
pyrazole
Prior art date
Application number
HK15103083.5A
Other languages
English (en)
Inventor
Fucheng Qu
Nathan Bryan Mantlo
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48428684&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1202542(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1202542A1 publication Critical patent/HK1202542A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
HK15103083.5A 2012-05-10 2015-03-26 新型吡唑化合物 HK1202542A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261645101P 2012-05-10 2012-05-10
US201361769221P 2013-02-26 2013-02-26
PCT/US2013/039164 WO2013169546A1 (en) 2012-05-10 2013-05-02 Pyrazole compounds as sglt1 inhibitors

Publications (1)

Publication Number Publication Date
HK1202542A1 true HK1202542A1 (zh) 2015-10-02

Family

ID=48428684

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103083.5A HK1202542A1 (zh) 2012-05-10 2015-03-26 新型吡唑化合物

Country Status (43)

Country Link
US (2) US8697849B2 (zh)
EP (1) EP2850084B1 (zh)
JP (1) JP6148725B2 (zh)
KR (1) KR101685779B1 (zh)
AP (1) AP3593A (zh)
AR (1) AR090806A1 (zh)
AU (1) AU2013259946B2 (zh)
BR (1) BR112014026198B1 (zh)
CA (1) CA2869323C (zh)
CL (1) CL2014002845A1 (zh)
CO (1) CO7141429A2 (zh)
CR (1) CR20140473A (zh)
CY (1) CY1117912T1 (zh)
DK (1) DK2850084T3 (zh)
DO (1) DOP2014000250A (zh)
EA (1) EA024207B1 (zh)
EC (1) ECSP14026088A (zh)
ES (1) ES2588835T3 (zh)
GT (1) GT201400242A (zh)
HK (1) HK1202542A1 (zh)
HR (1) HRP20160804T1 (zh)
HU (1) HUE030414T2 (zh)
IL (1) IL235427A (zh)
IN (1) IN2014DN07996A (zh)
JO (1) JO3136B1 (zh)
LT (1) LT2850084T (zh)
MA (1) MA37501B1 (zh)
ME (1) ME02405B (zh)
MX (1) MX357058B (zh)
MY (1) MY177326A (zh)
NZ (1) NZ700356A (zh)
PE (1) PE20142399A1 (zh)
PH (1) PH12014502492B1 (zh)
PL (1) PL2850084T3 (zh)
PT (1) PT2850084T (zh)
RS (1) RS55107B1 (zh)
SG (1) SG11201407345QA (zh)
SI (1) SI2850084T1 (zh)
TN (1) TN2014000410A1 (zh)
TW (1) TWI579295B (zh)
UA (1) UA113086C2 (zh)
WO (1) WO2013169546A1 (zh)
ZA (1) ZA201407531B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA113086C2 (xx) * 2012-05-10 2016-12-12 Піразольні сполуки як інгібітори sglt1
TW201425326A (zh) 2012-10-05 2014-07-01 Lilly Co Eli 新穎脲化合物
AR097890A1 (es) 2013-10-17 2016-04-20 Lilly Co Eli Compuestos de urea
AR098134A1 (es) 2013-11-01 2016-05-04 Lilly Co Eli Compuestos de urea
AR098670A1 (es) 2013-11-08 2016-06-08 Lilly Co Eli Inhibidor de sglt1
CN110054657B (zh) * 2018-01-18 2021-06-29 亚宝药业集团股份有限公司 吡喃葡萄糖取代的吡唑化合物及其制备方法
US10988462B2 (en) * 2018-04-04 2021-04-27 Japan Tobacco Inc. Pyrazole compounds substituted with heteroaryl and pharmaceutical use thereof
EP4026564A4 (en) * 2019-09-04 2023-03-15 Japan Tobacco Inc. THERAPEUTIC OR PROPHYLACTIC PROCEDURE FOR DIABETES USING COMBINATION MEDICATION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE264337T1 (de) 1999-08-31 2004-04-15 Kissei Pharmaceutical Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung
EP1364957B1 (en) 2001-02-26 2008-12-31 Kissei Pharmaceutical Co., Ltd. Glycopyranosyloxypyrazole derivatives and medicinal use thereof
CA2448741C (en) 2001-05-30 2010-06-22 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
AU2003254847B2 (en) * 2002-08-08 2009-06-04 Kissei Pharmaceutical Co., Ltd. Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
DE102004028241B4 (de) * 2004-06-11 2007-09-13 Sanofi-Aventis Deutschland Gmbh Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
RU2437876C2 (ru) * 2006-05-19 2011-12-27 Тайсо Фармасьютикал Ко., Лтд. Соединение с-фенилглицитола для лечения диабета
AU2008344436B2 (en) 2007-12-27 2013-08-29 Kissei Pharmaceutical Co., Ltd. Monosebacate of pyrazole derivative
BRPI1008653A2 (pt) 2009-02-23 2016-03-08 Taisho Pharmaceutical Co Ltd compostos 4-isopropil fenil glicitol como inibidores de sglt1
EP2482823A2 (en) 2009-10-02 2012-08-08 Sanofi Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
UA113086C2 (xx) * 2012-05-10 2016-12-12 Піразольні сполуки як інгібітори sglt1

Also Published As

Publication number Publication date
PL2850084T3 (pl) 2017-05-31
CL2014002845A1 (es) 2015-01-30
HRP20160804T1 (hr) 2016-08-12
AP3593A (en) 2016-02-15
US9296775B2 (en) 2016-03-29
MX357058B (es) 2018-06-25
AU2013259946A1 (en) 2014-10-16
RS55107B1 (sr) 2016-12-30
ECSP14026088A (es) 2015-09-30
CY1117912T1 (el) 2017-05-17
EA024207B1 (ru) 2016-08-31
EP2850084A1 (en) 2015-03-25
TW201406773A (zh) 2014-02-16
ME02405B (me) 2016-09-20
MA37501B1 (fr) 2016-11-30
CN104284894A (zh) 2015-01-14
KR20150001798A (ko) 2015-01-06
CN104284894B (zh) 2016-02-17
BR112014026198B1 (pt) 2021-02-02
JP6148725B2 (ja) 2017-06-14
PT2850084T (pt) 2016-08-02
PH12014502492A1 (en) 2015-01-12
AR090806A1 (es) 2014-12-10
TWI579295B (zh) 2017-04-21
JO3136B1 (ar) 2017-09-20
IN2014DN07996A (zh) 2015-05-01
EP2850084B1 (en) 2016-06-15
WO2013169546A1 (en) 2013-11-14
MY177326A (en) 2020-09-11
NZ700356A (en) 2016-06-24
DK2850084T3 (en) 2016-09-12
TN2014000410A1 (en) 2015-12-21
PH12014502492B1 (en) 2015-01-12
CR20140473A (es) 2014-11-21
GT201400242A (es) 2015-08-27
MA37501A1 (fr) 2016-03-31
SG11201407345QA (en) 2014-12-30
MX2014013615A (es) 2015-02-12
US20140162967A1 (en) 2014-06-12
AP2014008044A0 (en) 2014-11-30
AU2013259946B2 (en) 2015-09-10
KR101685779B1 (ko) 2016-12-12
UA113086C2 (xx) 2016-12-12
BR112014026198A2 (pt) 2017-06-27
CA2869323C (en) 2016-03-29
US20130303471A1 (en) 2013-11-14
ZA201407531B (en) 2016-05-25
SI2850084T1 (sl) 2016-07-29
CO7141429A2 (es) 2014-12-12
CA2869323A1 (en) 2013-11-14
JP2015516419A (ja) 2015-06-11
DOP2014000250A (es) 2014-11-30
PE20142399A1 (es) 2015-01-22
IL235427A (en) 2016-06-30
US8697849B2 (en) 2014-04-15
ES2588835T3 (es) 2016-11-07
EA201491852A1 (ru) 2015-02-27
HUE030414T2 (en) 2017-05-29
LT2850084T (lt) 2016-09-12

Similar Documents

Publication Publication Date Title
HK1210775A1 (zh) 作為激酶抑制劑的咪唑並三嗪甲腈
HK1208442A1 (zh) 作為 激酶抑制劑的取代的吡咯並嘧啶基氨基－苯並噻唑酮
HK1211921A1 (zh) 抑制劑化合物
IL228103A0 (en) Amino-quinolines as kinase inhibitors
EP2685992A4 (en) AMINO-QUINOLINES AS KINASE INHIBITORS
HRP20160804T1 (hr) Spojevi pirazola kao inhibitori sglt1
HK1207366A1 (zh) 作為 抑制劑的塞二唑啉酮二酮
SG11201500973WA (en) Amino-quinolines as kinase inhibitors
EP2928888A4 (en) SUBSTITUTED PYRIDOPYRAZINES AS SYK INHIBITORS
HK1209422A1 (zh) 抑制劑
HK1213253A1 (zh) 新型吡唑衍生物
GB201211019D0 (en) Inhibitor compounds
ZA201303800B (en) Pyrazole compounds
GB201219289D0 (en) Pyrazole derivatives
GB201219296D0 (en) Pyrazole derivatives
GB201218245D0 (en) Pyrazole derivatives